FindTrial
Sign In

Duration of post operative analgesia in patients undergoing unilateral breast surgeries with bupivacaine plus adjuvants

A Comparative Study of Bupivacaine with Dexmedetomidine versus Bupivacaine with Dexamethasone in Ultrasound Guided Serratus Anterior Plane Block for Post Operative Analgesia in Unilateral Breast Surgeries - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065595
Enrollment
102
Registered
2024-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Serratus anterior plane block: Comparing the above mentioned block between bupivacaine 0.25% with dexmetedomidine versus bupivacaine 0.25% with dexamethasone Control Intervention1: Nil:

Sponsors

Krishna K
Lead Sponsor
Dr Bhavyashree G Y
Collaborator
Dr shashikumar P
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: patients undergoing elective unilateral breast surgeries, asa grade I and II

Exclusion criteria

Exclusion criteria: patients allergic to local anaesthetic , diabetic, bleeding disorder, local infection

Design outcomes

Primary

MeasureTime frame
To compare the duration of postoperative analgesia between bupivacaine 0.25% with dexmedetomidine 50 micro gram with dexamethasone 4mg in unilateral breast surgeriesTimepoint: 24 hours—

Secondary

MeasureTime frame
complication of nausea and vomitingTimepoint: 24 hours—

Countries

India

Contacts

Public ContactDr Krishna K

Mandya Institute of Medical Science

drkris66@gmail.com9448046220

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026